FoodMar 25, 2020
Juanita's Foods Hot & Spicy Menudo recall — FDA F-0836-2020
A small amount of product that was on hold due to potential for metal contamination was released into distribution.
Class IIFDA: TerminatedJuanita's Foods Inc.
Monthly breakdown
2020 recalls by month
Select a month to review the recall records reported during that period.
December 2020315 records · 4 categoriesNovember 2020241 records · 4 categoriesOctober 2020416 records · 4 categoriesSeptember 2020371 records · 4 categoriesAugust 2020245 records · 4 categoriesJuly 2020442 records · 4 categoriesJune 2020342 records · 4 categoriesMay 2020315 records · 4 categoriesApril 2020422 records · 4 categoriesMarch 2020368 records · 4 categoriesFebruary 2020551 records · 4 categoriesJanuary 2020224 records · 4 categories
2020 recalls — page 133
Records are ordered by the best available source date.
FoodMar 25, 2020
Pero Family Farms Fresh n' Savory Simple Side Kit Zucchini recall — FDA F-0844-2020
Undeclared allergens of egg and milk due to incorrect label
Class IFDA: TerminatedPero Family Farms Company
FoodMar 25, 2020
Chicago Indoor Garden Sprout Salad 6 oz recall — FDA F-0860-2020
FDA sample analysis of sprouts was positive for E. coli. FDA traceback and epi associate the firms sprouts with an outbreak of E. coli.
Class IFDA: TerminatedChicago Indoor Garden, Inc.
DrugMar 25, 2020
Atorvastatin Calcium Tablets, USP 40 mg recall — FDA D-1047-2020
Presence of foreign substance: Foreign matter has been identified as latex glove in one lot of Atorvastatin Calcium Tablets USP 40 mg.
Class IIFDA: TerminatedSun Pharmaceutical Industries, Inc.
DrugMar 25, 2020
Med Man Distribution UP2, Dietary Supplement, All Natural Libido for Men & Women, a) one recall — FDA D-1036-2020
Marketed without an Approved NDA/ANDA: Product contains undeclared sildenafil which was discovered through FDA analysis.
Class IFDA: TerminatedMed Man Distribution, Inc.
DrugMar 25, 2020
Breckenridge Pharmaceutical Solifenacin Succinate Tablets, 5mg recall — FDA D-1050-2020
CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might convert to Solifenacin Tartrate Tablets.
Class IIFDA: TerminatedBreckenridge Pharmaceutical, Inc.
DrugMar 25, 2020
Breckenridge Pharmaceutical Solifenacin Succinate Tablets, 10 mg recall — FDA D-1051-2020
CGMP Deviations: During manufacturing Solifenacin Succinate Tablets might convert to Solifenacin Tartrate Tablets.
Class IIFDA: TerminatedBreckenridge Pharmaceutical, Inc.
DrugMar 25, 2020
Perrigo Company PLC Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 95 recall — FDA D-1026-2020
CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
Class IIFDA: TerminatedPerrigo Company PLC
DrugMar 25, 2020
Perrigo Company PLC Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg recall — FDA D-1023-2020
CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
Class IIFDA: TerminatedPerrigo Company PLC
DrugMar 25, 2020
Perrigo Company PLC Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 65 recall — FDA D-1022-2020
CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
Class IIFDA: TerminatedPerrigo Company PLC
DrugMar 25, 2020
Doxycycline Capsules, USP, 100 mg, 50-count bottle recall — FDA D-1033-2020
CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Class IIFDA: TerminatedSun Pharmaceutical Industries, Inc.
DrugMar 25, 2020
Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count bottle recall — FDA D-1029-2020
Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chloride Tablets 750 mg.
Class IIIFDA: TerminatedStrides Pharma Science Limited
DrugMar 25, 2020
Perrigo Company PLC Maximum Strength Acid Reducer, Cool Mint Ranitidine tablets, USP 150 mg recall — FDA D-1019-2020
CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
Class IIFDA: TerminatedPerrigo Company PLC
DrugMar 25, 2020
Perrigo Company PLC Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 200 recall — FDA D-1028-2020
CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
Class IIFDA: TerminatedPerrigo Company PLC
DrugMar 25, 2020
RemedyRepack Lisinopril/HCTZ 20mg/12.5mg Tablet, QTY: 30 tablets per blister card, MFG recall — FDA D-1030-2020
Presence of Foreign Tablets/Capsules: This is a spin-off recall of D-1581-2019 due to a product complaint where one of Lupin's Fenofibrate 145mg was observed in the 500 s count product…
Class IIFDA: TerminatedRemedyRepack Inc.
DrugMar 25, 2020
Doxycycline Capsules, USP, 75 mg, 100-count bottle recall — FDA D-1032-2020
CGMP Deviations: Doxycycline capsules were not manufactured under Current Good Manufacturing Practice conditions.
Class IIFDA: TerminatedSun Pharmaceutical Industries, Inc.
DrugMar 25, 2020
Perrigo Company PLC Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 24 recall — FDA D-1018-2020
CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
Class IIFDA: TerminatedPerrigo Company PLC
DrugMar 25, 2020
Perrigo Company PLC Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 30 tablets recall — FDA D-1012-2020
CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
Class IIFDA: TerminatedPerrigo Company PLC
DrugMar 25, 2020
Med Man Distribution Bow & Arrow, Dietary Supplement, Libido Enhancer for Men, a) Four pack recall — FDA D-1037-2020
Marketed without an Approved NDA/ANDA: Product contains undeclared sildenafil which was discovered through FDA analysis.
Class IFDA: TerminatedMed Man Distribution, Inc.
DrugMar 25, 2020
Perrigo Company PLC Maximum Strength Acid Reducer, Ranitidine tablets, USP 150 mg, 50 recall — FDA D-1021-2020
CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
Class IIFDA: TerminatedPerrigo Company PLC
DrugMar 25, 2020
Perrigo Company PLC Regular Strength Acid Reducer, Ranitidine tablets, USP 75 mg, 80 tablets recall — FDA D-1014-2020
CGMP Deviation; Possible contamination with impurity N-nitrosodimethylamine.
Class IIFDA: TerminatedPerrigo Company PLC
VehicleMar 19, 2020
Audi A6 starter motor recall — NHTSA campaign 20V153000
Volkswagen Group of America, Inc. (Volkswagen) is recalling certain 2019-2020 Audi A6 vehicles equipped with mild-hybrid technology and 2.0TFSI engines. Moisture may enter the starter…
starter motorVolkswagen Group of America, Inc.
VehicleMar 19, 2020
Highlander delivery recall — NHTSA campaign 20V162000
Toyota Motor Engineering & Manufacturing (Toyota) is recalling certain 2020 Highlander vehicles equipped with a 3.5 L, V6 (2GR-FKS) gasoline engine. Due to an Engine Control Unit (ECU)…
deliveryToyota Motor Engineering & Manufacturing
VehicleMar 19, 2020
BMW buckle recall — NHTSA campaign 20V164000
BMW of North America, LLC (BMW) is recalling certain 2020 X3 xDrive30e, X4 xDrive30i, X4 M40i, X4M, 330i, 330i xDrive, M340i, 840i Gran Coupe, 840i xDrive Gran Coupe, M850i xDrive Gran…
buckleBMW of North America, LLC
About the 2020 recall archive
This archive groups records by their reported or recall date. It does not imply that every recall was initiated, announced and resolved during the same calendar year. Open the individual record for the exact dates and source details supplied by FDA or NHTSA.